Richard Sever

Richard Sever

@richardsever.bsky.social

Chief Science and Strategy Officer, openRxiv. Co-Founder, bioRxiv and medRxiv.

16K followers427 following3.1K posts

This is a completely different question from debating the relative merits of human (peer) versus machine (not peer) review, on which views differ and are shifting.

Also: of those who said "yes", 2% named Elon Musk..

Katie Mack@astrokatie.com

Every year, Research!America does a poll that asks, "Can you name a living scientist?" In January 2026, 76% of respondents said "no." Of those who said "yes," 5% named a scientist who was, in fact, dead. www.researchamerica.org/blog/can-you...

Stay tuned for our Super Intelligence policies. Obviously they will be better

Richard Sever@richardsever.bsky.social

How we are approaching AI at openRxiv - new blog post prompted by growing adoption by researchers, submission patterns, and questions from the community openrxiv.org/approach-to-... 1/n

Richard Sever reposted

Replying to @richardsever.bsky.social

And with the spectrum of emerging AI review tools, novelty will clearly become an aspect judged/quantified/ranked/selected. So the drive for novelty will only increase. It just won't be Nature Editors who are blamed... 2/2

Richard Sever reposted

Replying to @ja.meswebber.com

Yeah - I guess the question is if it will ever be important enough to influence how research is performed or written - because that is what gaming would entail. But researchers already lament journals' (and funders') obsession with novelty. This may just make that worse... 1/2

Should OpenAlex have a 'novelty score'? I suspect many will reflexively recoil at the idea of an open academic index that likens itself to the library of Alexandria assigning an LLM-generated novelty score to papers (recall the response to QED's 1%..) 1/n blog.openalex.org/should-opena...

blog.openalex.orgShould OpenAlex publish a novelty score? A vibe check - OpenAlex blogWhen people want to know whether a piece of research is any good, they usually have two options: ask an expert, or count citations. Both have well-known problems. Expert review is slow, expensive, sub...

But we already have citations; Google Scholar, and even PubMed sort by 'relevance', etc. Meanwhile, journal brand and IF expose a deep desire within the academic community for leading indicators of quality (available long before citations accrue). So people may not want this but use it... 2/n

Note also that the OpenAlex survey is aimed at a variety of stakeholders, including funders, metascientists, publishers and researchers, and presents a variety of possible use cases. The wants, needs and opinions and needs will not necessarily align. 3/n

Why medRxiv: "Despite the FDA’s endorsement, many clinicians were hesitant..The solution was to post a preprint on medRxiv. Once it went online [they] began to adopt the method, making COVID testing more tolerable..before the peer-reviewed version was published" connect.biorxiv.org/news/2026/08...

connect.biorxiv.orgJerry Cangelosi — medRxiv userbioRxiv - the preprint server for biology, operated by openRxiv, a nonprofit organization dedicated to advancing scientific communication

Richard Sever reposted

Replying to @richardsever.bsky.social

In other words, it would be inadequate if that were all that were happening, but scrutiny by the community follows - that's the point. The decisions about what to exclude in the first place (screen out) versus have community assess (sunlight) are what we are talking about - and opinions vary... 3/n

Richard Sever reposted

Replying to @richardsever.bsky.social

Recall we are talking about preprint servers here. The aim is not to provide a source of validated peer-reviewed 'academic truth' but to try to exclude obviously false information and glut of zero value at all so what is posted can be critiqued, which may include pointing out false references.. 2/n

All decisions are made by human screeners at openRxiv. We use automated tools, including LLMs and AI detectors, only to assist us. We also maintain our 'do no harm' rules and take expert advice on biosecurity risks of papers, including in silico work, in general and on a case-by-case basis 6/n

Most importantly, we will remain adaptive. No-one knows what the world will look like in a few years, and our approach may change. Our primary goal is to maintain a service that benefits the community. That includes authors and readers (human and machine), whose desires may sometimes conflict 7/n

We don't want to penalize AI use but note it is enabling generation of both AI slop and submissions that are technically correct but of no use to the research community. It has always been our policy to decline such 'facile' submissions; they are just easier to generate now (to pad CVs). 4/n

We therefore reserve the right - as we have always done - to decline submissions or rate limit authors in some instances where there are indications this the case (e.g. entirely AI-generated discussions, large numbers of hallucinated references, high volumes of cookie-cutter facile submissions) 5/n

AI is now widely adopted by researchers throughout the research workflow. There are benefits and drawback we must balance for authors and readers to maintain the utility of the servers, and we are applying long-standing principles in this context. 2/n

Authors must be accountable for AI use, have intellectual input into the work and its interpretations. They must be verifiable human beings and affiliated with a verifiable organization to which we can turn if there are issues/allegations of misconduct. 3/n

THIS Or apply a level of trust many are not comfortable with or, worse, trust only things by certain people, which even fewer should be comfortable with and the PubPeer experience tells us is naive...

Andy Fraser@andyfraser.bsky.social

Absolutely. We cannot identify fakes so we have to watermark genuine data. End to end. It’s our only hope for survival.

Richard Sever reposted

Replying to @richardsever.bsky.social

I think my ability to detect falsified data in genomics disappeared 20 years ago at least. Seriously, nobody checks if data are real in massive datasets - how even would you? We have had to take data on faith for a long time, a major reviewing issue but I don’t see a fix.

Retracting then republishing a corrected paper recognizes the reality that errors are made but can be corrected (though blurs the line with Corrigenda). Similarly we see Withdrawals on biorxiv/medRxiv that are subsequently updated with a corrected paper. retractionwatch.com/2026/10/15/j...

retractionwatch.comJournal retracts, republishes paper on Long COVID treatment trialAnnals of Internal Medicine has retracted a paper on treatments for Long COVID because the authors did not report dosing information for metformin, one of the drugs tested in the study. The editor-…

If he saw the world with a blue tint, why would he not see his paint palette with that same tint and thus create paintings we see without it?

Claude Monet@monet.bsky.social

For years, Monet feared eye surgery more than blindness. At age 82, cataracts had clouded his vision so badly that he finally agreed to operations. The surgery restored much of his sight—but left him seeing the world with a bluish tint.

Richard Sever reposted

Replying to @wkhuber.bsky.social

As I was taught as a graduate student 40 years ago by Gerd Jürgens: “If you can’t convince them, confuse them. And if you are short of data, use color.” (color 1986 = fancy graphics & figures with dozens of panels 2026)

"Because manuscripts reflected real progress towards our field’s goals, our assessment systems began relying on them as primary metrics...which is obviously flawed...Generative AI has broken this already-flawed proxy completely" journals.plos.org/plosbiology/...

journals.plos.orgWhat is biology research for?In the age of generative artificial intelligence (AI), the assumption that writing a paper requires doing science no longer holds true. Before deciding how to respond to the surge of AI-generated pape...

"Open science has been building standards and norms...AI has ignored this...just sucked everything in..we need to reclaim ownership" Some of us have said for years we need more nuance to openness given the potential for extractive commercial re-use 1/n scedmunds.substack.com/p/sage-advic...

scedmunds.substack.comSage Advice From The FAIR Data FerryportHere are some thoughts from the 2026 Sage Assembly, Sage Bionetworks comeback meeting tackling “Trust in the Machine: Verification, Agency, and the Future of Scientific Work.”

Entirely unrestricted licenses, for example, not only limit possible sustainability models but enable reuse/resale in ways that may harm authors and the ecosystem itself. AI has exposed this, and even Creative Commons are concerned. (a complex issue and not clear any license can solve this). 2/n

"As open as possible, as closed as necessary" is a phrase used when discussing open science in the context of patient privacy, biosecurity, etc. Perhaps we should apply it more broadly as we think of how we structure and maintain a healthy 'open' science ecosystem. 3/n

Richard Sever reposted

You know a gene is selfish when its DNA twists the wrong way, as demonstrated by the left-handed double-helix proudly adorning the 50th Anniversary Edition of the multimillion copy bestseller on this topic.

Richard Sever reposted

Very nice discovery from the Jackson, Bravo and Basel labs. Cleaved tRNA ends, loaded with an amino acid, activate a form of bacterial immunity

bioRxiv Microbiology@biorxiv-microbiol.bsky.social

Aminoacylated tRNA tails trigger auxiliary bacterial immunity https://www.biorxiv.org/content/10.64898/2026.10.14.759216v1

Richard Sever reposted

In response to the government’s renaming of AI to SI, I propose all journals rename Supplemental Information to Additional Information.